Pharmacokinetics of a new thromboxane A2 receptor antagonist, S-1452, and its effect on platelet aggregation in healthy volunteers

Journal of Clinical Pharmacology

Volumn 36, Issue 5, 1996, Pages 409-413

  Fujimura, Akio ^a   Shiga, Tsuyoshi ^a   Kumagai, Yuji ^a   Ohashi, Kyo Ichi ^a   Ebihara, Akio ^a   Kotegawa, Tsutomu ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOMITROBAN; DRUG METABOLITE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

EID: 0029991631     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb05027.x     Document Type: Article

References (11)

1. 2. Fed Proc 1987;46:133-138.
2. 2 receptor antagonist. J Organic Chem 1991;56:2122-2127.
3. 2 receptor antagonist, S-145, on collagen-induced ECG changes and thrombocytopenia in rodents. Jpn J Pharmacol 1989;50:195-205.
4. 2 antagonist, S-1452, in guinea pigs. Int Arch Allergy Immunol 1992;98:239-246.
5. 2 in bronchial hyperresponsiveness but not lung inflammation induced by bacterial lipopoly-saccharide in guinea pigs. Eur J Pharmacol 1993;231:13-21.
6. 2 receptor antagonist. Cardiovasc Drug Rev 1992;10:280-295.
7. 2 receptor antagonist S-1452 and its metabolites in human plasma. J Chromatogr 1992;583:45-52.
8. 2 receptor antagonist S-1452 and its metabolites in human urine. J Chromatogr 1992;583:53-62.
9. Marcus AJ: Hemorrhagic disorders: abnormalities of platelet and vascular function. In, Weingaarden JB, Smith LH (eds.): Cecil Textbook of Medicine. Sixteenth edition. Philadelphia: WB Saunders, 1982;979-982.
10. Fujimura A, Ohashi K, Ebihara A: Daily variations in platelet aggregation and adhesion in healthy subjects. Life Sci 1992;50: 1043-1047.
11. 2 receptor of the antagonist, S-145. Br J Pharmacol 1991;103: 1383-1888.